GHDX Financial Facts

Research and development: 13.48M
Cost of product revenues: 13.72M
See Full Income Statement

Accumulated deficit: -225.43M
Other current liabilities: 208K
See Full Balance Sheet

Genomic Health Inc. (GHDX) Earnings

  |   Expand Research on GHDX
Next EPS Date 5/4/16 *Est. EPS Growth Rate +100.0% *Last Qtr.
Average EPS % Beat Rate -28.4% Revenue Growth Rate -100.0% *Last Qtr.
Average % Move 1-Wk after EPS +3.3% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/10/16 Q415 N/A-$0.09 N/A N/A$74.87M = N/A N/A
11/3/15 Q315 -$0.36-$0.18 -$0.18$73.6M$73.12M = Details
8/4/15 Q215 -$0.29-$0.27 -$0.02$70.6M$71.65M = Details
5/5/15 Q115 -$0.30-$0.26 -$0.04$68.2M$69.9M = Details
2/10/15 Q414 -$0.20-$0.22 +$0.02$69.1M$72.2M = Details
11/4/14 Q314 -$0.20-$0.22 +$0.02$69.1M$71M = Details
8/5/14 Q214 N/A-$0.26 N/A N/A$69.04M = N/A N/A
5/6/14 Q114 -$0.24-$0.18 -$0.06$67M$68.47M = Details